Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 615

1.

Externally Delivered Focused Ultrasound for Renal Denervation.

Neuzil P, Ormiston J, Brinton TJ, Starek Z, Esler M, Dawood O, Anderson TL, Gertner M, Whitbourne R, Schmieder RE.

JACC Cardiovasc Interv. 2016 Jun 27;9(12):1292-9. doi: 10.1016/j.jcin.2016.04.013. Epub 2016 Jun 20.

PMID:
27339848
2.

Improvement in Retinal Capillary Rarefaction After Valsartan Treatment in Hypertensive Patients.

Jumar A, Harazny JM, Ott C, Kistner I, Friedrich S, Schmieder RE.

J Clin Hypertens (Greenwich). 2016 Jun 16. doi: 10.1111/jch.12851. [Epub ahead of print]

3.

Early signs of end-organ damage in retinal arterioles in patients with type 2 diabetes compared to hypertensive patients.

Jumar A, Ott C, Kistner I, Friedrich S, Michelson G, Harazny JM, Schmieder RE.

Microcirculation. 2016 Jun 7. doi: 10.1111/micc.12291. [Epub ahead of print]

PMID:
27270643
4.

Why in 2016 are patients with hypertension not 100% controlled? A call to action.

Redon J, Mourad JJ, Schmieder RE, Volpe M, Weiss TW.

J Hypertens. 2016 Jun 6. [Epub ahead of print]

PMID:
27270186
5.

Non-invasive Renal Denervation: Update on External Ultrasound Approaches.

Schmieder RE, Ott C, Bramlage P.

Curr Hypertens Rep. 2016 Jun;18(6):48. doi: 10.1007/s11906-016-0653-6. Review.

PMID:
27137523
6.

Renal denervation in hypertensive patients not on blood pressure lowering drugs.

De Jager RL, Sanders MF, Bots ML, Lobo MD, Ewen S, Beeftink MM, Böhm M, Daemen J, Dörr O, Hering D, Mahfoud F, Nef H, Ott C, Saxena M, Schmieder RE, Schlaich MP, Spiering W, Tonino PA, Verloop WL, Vink EE, Vonken EJ, Voskuil M, Worthley SG, Blankestijn PJ.

Clin Res Cardiol. 2016 Apr 22. [Epub ahead of print]

PMID:
27105858
7.

Benefits and Risks of Aliskiren Treatment in Patients With Type 2 Diabetes: Analyses of the 3A Registry.

Kistner I, Zeymer U, Dechend R, Hagedorn I, Riemer T, Bramlage P, Pittrow D, Senges J, Schmieder RE.

J Clin Hypertens (Greenwich). 2016 Apr 20. doi: 10.1111/jch.12828. [Epub ahead of print]

8.

Platelet CD40 contributes to enhanced monocyte chemoattractant protein 1 levels in patients with resistant hypertension.

Stumpf C, Raaz D, Klinghammer L, Schneider M, Schmieder RE, Garlichs CD, Achenbach S.

Eur J Clin Invest. 2016 Jun;46(6):564-71. doi: 10.1111/eci.12635.

PMID:
27090943
9.

The Effect of Resting Heart Rate on the New Onset of Microalbuminuria in Patients With Type 2 Diabetes: A Subanalysis of the ROADMAP Study.

Schmieder RE, Bramlage P, Haller H, Ruilope LM, Böhm M; ROADMAP Investigators.

Medicine (Baltimore). 2016 Apr;95(15):e3122. doi: 10.1097/MD.0000000000003122.

10.

Reproducibility of Kidney Perfusion Measurements With Arterial Spin Labeling at 1.5 Tesla MRI Combined With Semiautomatic Segmentation for Differential Cortical and Medullary Assessment.

Hammon M, Janka R, Siegl C, Seuss H, Grosso R, Martirosian P, Schmieder RE, Uder M, Kistner I.

Medicine (Baltimore). 2016 Mar;95(11):e3083. doi: 10.1097/MD.0000000000003083.

11.

Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry.

Gitt AK, Bramlage P, Potthoff SA, Baumgart P, Mahfoud F, Buhck H, Ehmen M, Ouarrak T, Senges J, Schmieder RE; EARLY Registry Group.

BMC Cardiovasc Disord. 2016 Mar 8;16:56. doi: 10.1186/s12872-016-0222-6.

12.

Is Azilsartan More Effective in Younger Than in Older Patients? An Explorative Analysis of the Prospective EARLY Registry.

Schmieder RE, Bramlage P; EARLY Registry Group.

J Clin Hypertens (Greenwich). 2016 Mar 3. doi: 10.1111/jch.12804. [Epub ahead of print] No abstract available.

13.

Complex reinnervation pattern after unilateral renal denervation in rats.

Rodionova K, Fiedler C, Guenther F, Grouzmann E, Neuhuber W, Fischer MJ, Ott C, Linz P, Freisinger W, Heinlein S, Schmidt ST, Schmieder RE, Amann K, Scrogin K, Veelken R, Ditting T.

Am J Physiol Regul Integr Comp Physiol. 2016 May 1;310(9):R806-18. doi: 10.1152/ajpregu.00227.2014. Epub 2016 Feb 24.

PMID:
26911463
14.

Adherence to Antihypertensive Medication in Treatment-Resistant Hypertension Undergoing Renal Denervation.

Schmieder RE, Ott C, Schmid A, Friedrich S, Kistner I, Ditting T, Veelken R, Uder M, Toennes SW.

J Am Heart Assoc. 2016 Feb 12;5(2). pii: e002343. doi: 10.1161/JAHA.115.002343.

15.

Baseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry).

Reinecke H, Breithardt G, Engelbertz C, Schmieder RE, Fobker M, Pinnschmidt HO, Schmitz B, Bruland P, Wegscheider K, Pavenstädt H, Brand E.

PLoS One. 2016 Feb 9;11(2):e0148057. doi: 10.1371/journal.pone.0148057. eCollection 2016.

16.

Central arteriovenous anastomosis and hypertension - Authors' reply.

Lobo MD, Sobotka PA, Dolan E, Witkowski A, Schmieder RE; ROX CONTROL HTN Investigators.

Lancet. 2015 Nov 7;386(10006):1821-2. doi: 10.1016/S0140-6736(15)00762-X. No abstract available.

PMID:
26843306
17.

Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke.

Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Guan TR, Zhang Y, Zhang X, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z, Zhu D, Rodicio JL, Ruilope LM, Martell-Claros N, Pinto F, Schmieder RE, Burnier M, Banach M, Cifkova R, Farsang C, Konradi A, Lazareva I, Sirenko Y, Dorobantu M, Postadzhiyan A, Accetto R, Jelakovic B, Lovic D, Manolis AJ, Stylianou P, Dicker D, Wei G, Xu C, Xie H, Coca A, O'Brien J, Ford G; ESH-CHL-SHOT trial investigators.

J Hypertens. 2016 Mar;34(3):393-6. doi: 10.1097/HJH.0000000000000853. No abstract available.

PMID:
26780185
18.

Deletion or Inhibition of the Oxygen Sensor PHD1 Protects against Ischemic Stroke via Reprogramming of Neuronal Metabolism.

Quaegebeur A, Segura I, Schmieder R, Verdegem D, Decimo I, Bifari F, Dresselaers T, Eelen G, Ghosh D, Davidson SM, Schoors S, Broekaert D, Cruys B, Govaerts K, De Legher C, Bouché A, Schoonjans L, Ramer MS, Hung G, Bossaert G, Cleveland DW, Himmelreich U, Voets T, Lemmens R, Bennett CF, Robberecht W, De Bock K, Dewerchin M, Ghesquière B, Fendt SM, Carmeliet P.

Cell Metab. 2016 Feb 9;23(2):280-91. doi: 10.1016/j.cmet.2015.12.007. Epub 2016 Jan 7.

PMID:
26774962
19.

Impaired excitability of renal afferent innervation after exposure to the inflammatory chemokine CXCL1.

Ditting T, Freisinger W, Rodionova K, Schatz J, Lale N, Heinlein S, Linz P, Ott C, Schmieder RE, Scrogin KE, Veelken R.

Am J Physiol Renal Physiol. 2016 Mar 1;310(5):F364-71. doi: 10.1152/ajprenal.00189.2015. Epub 2015 Dec 23.

PMID:
26697980
20.

The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry.

Bramlage P, Schmieder RE, Gitt AK, Baumgart P, Mahfoud F, Buhck H, Ouarrak T, Ehmen M, Potthoff SA; EARLY Registry Group.

Trials. 2015 Dec 19;16:581. doi: 10.1186/s13063-015-1100-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk